Introduction to Why Are High Quality Standardized Databases So Critical For Drug Development
Let's dive into the details surrounding Why Are High Quality Standardized Databases So Critical For Drug Development. Klaus Romero, MD, MS, Executive Director of Clinical Pharmacology and Quantitative Medicine at
Why Are High Quality Standardized Databases So Critical For Drug Development Comprehensive Overview
Despite increasing numbers of drug targets and technologies, rare disease C-Path's Rare & Orphan Disease Conference was 2.5-day conference held Sept. 11-13, that included patients, providers, ... C-Path Special Adviser, Past President and CEO, Martha Brumfield, PhD, discusses why data sharing is
Join us for a webinar on: Patient Registries Natural History Studies The
Summary & Highlights for Why Are High Quality Standardized Databases So Critical For Drug Development
- Endpoints in rare disease programs, like Clinical Outcome Assessments and surrogates (e.g., biomarkers), can be challenging to ...
- A look at the UK Biobank and how it will enable the
- Billy Dunn, MD, Director, CDER, Division of Neurology Products and Theresa Mullin, PhD, Associate Director of Strategic ...
- Cheminformatics is the backbone of modern
- Presented by Yafei Chen, MS, Senior Research Fellow, at the 64ᵗʰ Annual Annual Meeting and ToxExpo in Orlando, FL.
That wraps up our extensive overview of Why Are High Quality Standardized Databases So Critical For Drug Development.
